Adrian Johnson

In a recent press release, it was announced that Heart Aerospace, a Swedish company developing electric aircraft for regional travel, has raised $107 million in Series B funding. This funding round brings

TLDR: A recent survey conducted by Citeline and ICON Biotech reveals key insights and expectations for the biotech industry in 2024. The survey includes responses from 133 decision-makers in biotech organizations and

In a move that reflects the increasingly tense relationship between China and the U.S., Baidu’s venture capital affiliate, Baidu Venture, is reportedly in talks to sell its portfolio of stakes in several

TLDR: TechCrunch is a part of the Yahoo family of brands, including Yahoo and AOL. When using their sites and apps, they use cookies to provide services, authenticate users, and measure usage.

TLDR: StepStone Group has promoted eight professionals to partner and 18 to managing director in its latest round of promotions. One of the newly promoted partners is responsible for leading the firm’s

TLDR: Cohere Health, a clinical intelligence and prior authorization automation company based in Boston, has raised $50 million in equity funding. The funding round, led by Deerfield Management, brings the total amount

TLDR: Jack Selby, the long-time managing director of Thiel Capital and member of the “PayPal mafia,” discussed venture investing, luck, and the changing aspirations of entrepreneurs during a private event. Selby emphasized

TLDR: Venture capitalists are turning to the discounted secondary market to return funds to their investors. The European secondary market has seen a surge in funds buying up shares on the secondary

A new report from CBInsights has highlighted the state of AI funding over the past year. While the overall venture funding market saw a decline of 42% in 2023, AI funding fell

TLDR Venture capitalists are concerned about the Federal Reserve’s interest rate decisions. Early stage investors believe that interest rates are a distraction and should not be a major focus. Later stage investors